Keywords: mgi, methylgene, begin, kidney, cancer, trial, pharma

MGI and MethylGene begin kidney cancer trial

Article | 23 August 2001

Print This

MethylGene and MGI Pharma have initiated a Phase II clinical trial toevaluate the efficacy of their second-generation antisense inhibitor of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in